Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model

The tumor environment exerts a powerful suppressive influence on infiltrating tumor-reactive T cells. It induces tolerance of adoptively transferred effector T cells as they enter tumors and maintains the tolerance of persisting tumor-infiltrating T cells. In an autochthonous prostate cancer model,...

Full description

Bibliographic Details
Main Authors: Higham, Eileen M., Wittrup, Karl Dane, Chen, Jianzhu, Shen, Chase
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: The American Association of Immunologists 2012
Online Access:http://hdl.handle.net/1721.1/73448
https://orcid.org/0000-0003-2398-5896
https://orcid.org/0000-0002-5687-6154
_version_ 1826196402375491584
author Higham, Eileen M.
Wittrup, Karl Dane
Chen, Jianzhu
Shen, Chase
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Higham, Eileen M.
Wittrup, Karl Dane
Chen, Jianzhu
Shen, Chase
author_sort Higham, Eileen M.
collection MIT
description The tumor environment exerts a powerful suppressive influence on infiltrating tumor-reactive T cells. It induces tolerance of adoptively transferred effector T cells as they enter tumors and maintains the tolerance of persisting tumor-infiltrating T cells. In an autochthonous prostate cancer model, in which tumor-reactive CD8 T cells are trackable, we demonstrate that both depletion of endogenous dendritic cells (DCs) and intratumoral injection of Ag-loaded mature DCs delayed the tolerization of tumor-infiltrating effector CD8 T cells. Intratumoral injection of Ag-loaded DCs also reactivated tolerized CD8 T cells in the tumor tissue. The observed effects lasted as long as the injected DCs persisted. These findings are consistent with a critical role of DCs in modulating T cell reactivity in the tumor environment. They also suggest new potential strategies to extend the functionality of transferred effector T cells and to restore function to tolerized tumor-infiltrating T cells for cancer immunotherapy.
first_indexed 2024-09-23T10:26:16Z
format Article
id mit-1721.1/73448
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T10:26:16Z
publishDate 2012
publisher The American Association of Immunologists
record_format dspace
spelling mit-1721.1/734482022-09-30T21:08:07Z Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model Higham, Eileen M. Wittrup, Karl Dane Chen, Jianzhu Shen, Chase Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Chemical Engineering Koch Institute for Integrative Cancer Research at MIT Higham, Eileen M. Shen, Ching-Hung Wittrup, Karl Dane Chen, Jianzhu The tumor environment exerts a powerful suppressive influence on infiltrating tumor-reactive T cells. It induces tolerance of adoptively transferred effector T cells as they enter tumors and maintains the tolerance of persisting tumor-infiltrating T cells. In an autochthonous prostate cancer model, in which tumor-reactive CD8 T cells are trackable, we demonstrate that both depletion of endogenous dendritic cells (DCs) and intratumoral injection of Ag-loaded mature DCs delayed the tolerization of tumor-infiltrating effector CD8 T cells. Intratumoral injection of Ag-loaded DCs also reactivated tolerized CD8 T cells in the tumor tissue. The observed effects lasted as long as the injected DCs persisted. These findings are consistent with a critical role of DCs in modulating T cell reactivity in the tumor environment. They also suggest new potential strategies to extend the functionality of transferred effector T cells and to restore function to tolerized tumor-infiltrating T cells for cancer immunotherapy. National Science Foundation (U.S.) (Graduate Research Fellowship) National Institutes of Health (U.S.) (Grant CA100875) United States. Dept. of Defense (National Defense Science and Engineering Graduate Fellowship) David H. Koch Institute for Integrative Cancer Research at MIT (Research Fund) 2012-09-27T19:29:50Z 2012-09-27T19:29:50Z 2010-04 2010-01 Article http://purl.org/eprint/type/JournalArticle 0022-1767 1550-6606 http://hdl.handle.net/1721.1/73448 Higham, E. M. et al. “Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model.” The Journal of Immunology 184.11 (2010): 5954–5958. https://orcid.org/0000-0003-2398-5896 https://orcid.org/0000-0002-5687-6154 en_US http://dx.doi.org/10.4049/jimmunol.1000265 Journal of Immunology Creative Commons Attribution-Noncommercial-Share Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/ application/pdf The American Association of Immunologists PMC
spellingShingle Higham, Eileen M.
Wittrup, Karl Dane
Chen, Jianzhu
Shen, Chase
Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
title Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
title_full Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
title_fullStr Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
title_full_unstemmed Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
title_short Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model
title_sort cutting edge delay and reversal of t cell tolerance by intratumoral injection of antigen loaded dendritic cells in an autochthonous tumor model
url http://hdl.handle.net/1721.1/73448
https://orcid.org/0000-0003-2398-5896
https://orcid.org/0000-0002-5687-6154
work_keys_str_mv AT highameileenm cuttingedgedelayandreversaloftcelltolerancebyintratumoralinjectionofantigenloadeddendriticcellsinanautochthonoustumormodel
AT wittrupkarldane cuttingedgedelayandreversaloftcelltolerancebyintratumoralinjectionofantigenloadeddendriticcellsinanautochthonoustumormodel
AT chenjianzhu cuttingedgedelayandreversaloftcelltolerancebyintratumoralinjectionofantigenloadeddendriticcellsinanautochthonoustumormodel
AT shenchase cuttingedgedelayandreversaloftcelltolerancebyintratumoralinjectionofantigenloadeddendriticcellsinanautochthonoustumormodel